Washington D.C., Capitol Hill, Capitol Building, cherry blossoms
·
7 MIN READ

Meet the AMA’s Capitol Hill allies protecting patients and practices

Learn how a diverse group of lawmakers has worked with the AMA to carry favorable legislation over the finish line and block harmful measures.

Federal Advocacy
UPDATED
·
5 MIN READ

COVID-19 policy recommendations for OUD, pain, harm reduction

Download guidance and issue brief PDFs—the AMA provides policy recommendations to help guide policymakers to reduce the stress of patients with an opioid use disorder and pain during the COVID-19 outbreak.

series
Public Health
AMA COVID-19 Guides
·
6 MIN READ

Feb. 26, 2021: State Advocacy Update

South Dakota physician assistant independent practice bill defeated and more in the latest State Advocacy Update.

Advocacy Update
·
4 MIN READ

Feb. 5, 2021: National Advocacy Update

Expanding patients’ access to buprenorphine and more in the latest National Advocacy Update.

Advocacy Update
·
3 MIN READ

AMA in the News: January 2021

Read media highlights mentioning the American Medical Association for January 2021.

series
AMA in the News
AMA in the News
·
2 MIN READ

AMA statement on HHS decision to remove barriers for opioid treatment

AMA strongly endorses today’s decision by HHS to allow physicians to prescribe without a waiver highly effective medication for opioid use disorder.

Press Releases
·
3 MIN READ

Jan. 8, 2021: State Advocacy Update

Coverage for all forms of MOUD now required by Medicaid and more in the latest State Advocacy Update.

Advocacy Update
·
5 MIN READ

Overdose epidemic requires state action to remove barriers to care

AMA, Mannatt report emphasizes the increasing importance of removing barriers to evidence-based care.

Press Releases
·
4 MIN READ

As COVID-19 surges, AMA sounds alarm on nation’s overdose epidemic

Learn about the policy steps that must be taken to improve access to lifesaving substance-use disorder treatment.

Overdose Epidemic